Trade

with

Alcobra Ltd
(NASDAQ: ADHD)
AdChoices
5.12
-0.20
-3.76%
After Hours :
5.14
+0.02
+0.44%

Open

5.36

Previous Close

5.32

Volume (Avg)

491.25k (408.69k)

Day's Range

5.05-5.43

52Wk Range

5.01-25.44

Market Cap.

72.55M

Dividend Rate ( Yield )

-

Beta

-

Shares Outstanding

13.64M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Biotechnology
Highlights
Analyst Recommendation: Outperform
    • Revenue

    • 0

    • Net Income

    • -10.55M

    • Market Cap.

    • 72.55M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • -

    • Forward P/E

    • -4.09

    • Price/Sales

    • -

    • Price/Book Value

    • 1.97

    • Price/Cash flow

    • -3.80

      • EBITDA

      • -10.28M

      • Return on Capital %

      • -78.80

      • Return on Equity %

      • -85.87

      • Return on Assets %

      • -78.80

      • Book Value/Share

      • 2.60

      • Shares Outstanding

      • 13.64M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/20/2014
      Outperform
        • 1 Year Price Target

        • 26.33

        • Credit Rating

        • -

        • Analysts

        • 3

        • EPS Estimate

        • -1.59

        • Cashflow Estimate

        • -1.44

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 0.00

          • 40.73

          • Net Income

            YTD/YTD (last year)

          • -

          • 17.04

          • Net Income

            Q/Q (last year)

          • -

          • 98.90

          • Sales (Revenue)

            5-Year Annual Average

          • -

          • 63.43

          • Net Income

            5-Year Annual Average

          • -

          • 10.65

          • Dividends

            5-Year Annual Average

          • -

          • 15.81

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • -

            • 82.75

            • Pre-Tax Margin

            • -

            • 39.38

            • Net Profit Margin

            • -

            • 31.33

            • Average Gross Margin

              5-Year Annual Average

            • -

            • 82.99

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 33.42

            • Average Net Profit Margin

              5-Year Annual Average

            • -

            • 199.05B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.76

              • Current Ratio

              • 8.41

              • 2.92

              • Quick Ratio

              • 8.41

              • 2.35

              • Interest Coverage

              • -

              • 38.02

              • Leverage Ratio

              • 1.13

              • 2.21

              • Book Value/Share

              • 2.60

              • 4.76

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -2.79

                • 196.08

                • P/E Ratio 5-Year High

                • -14.16

                • 634.30

                • P/E Ratio 5-Year Low

                • -2.63

                • 124.82

                • Price/Sales Ratio

                • -

                • 9.12

                • Price/Book Value

                • 2.05

                • 8.26

                • Price/Cash Flow Ratio

                • -3.80

                • 47.39

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • -85.87

                    (-)

                  • 37.63

                    (27.20)

                  • Return on Assets %

                    (5-Year Average)

                  • -78.80

                    (-)

                  • 17.22

                    (13.81)

                  • Return on Capital %

                    (5-Year Average)

                  • -85.87

                    (-)

                  • 21.78

                    (17.31)

                  • Income/Employee

                  • -

                  • 117.08k

                  • Inventory Turnover

                  • -

                  • 1.48

                  • Asset Turnover

                  • -

                  • 0.55

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  -10.29M
                  Operating Margin
                  -
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  -3.80
                  Ownership

                  Institutional Ownership

                  33.77%

                  Top 10 Institutions

                  30.04%

                  Mutual Fund Ownership

                  7.51%

                  Float

                  48.66%

                  5% / Insider Ownership

                  -

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • JPM Global Healthcare

                  •  

                    668,643

                  • 0.00

                  • 4.90

                  • Interfund Eq USA

                  •  

                    236,718

                  • 14.60

                  • 1.74

                  • I.B.I Biotechnology

                  •  

                    72,000

                  • 80.00

                  • 0.53

                  • Carnegie Biotechnology

                  •  

                    24,600

                  • 0.00

                  • 0.18

                  • Market Vectors® Israel ETF

                  •  

                    5,913

                  • 0.00

                  • 0.01

                  • JCI Capital Sicav JC TR

                  •  

                    2,693

                  • 128.61

                  • 0.02

                  • Fidelity® NASDAQ Composite Index® Fund

                  •  

                    1,817

                  • 0.00

                  • 0.01

                  • Westcore Small-Cap Growth Fund

                  •  

                    1,198

                  • 9.01

                  • 0.01

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • J P Morgan Asset Management (UK) Ltd

                  •  

                    827,237

                  • +2.37%

                  • 6.07

                  • Knoll Capital Management LP

                  •  

                    687,000

                  • 0.00%

                  • 5.04

                  • Awm Investment Company Inc

                  •  

                    600,000

                  • 0.00%

                  • 4.40

                  • Great Point Partners LLC

                  •  

                    332,908

                  • +13.38%

                  • 2.44

                  • Sophrosyne Capital LLC

                  •  

                    303,576

                  • +11.10%

                  • 2.23

                  • FIDEURAM ASSET MANAGEMENT (IRELAND) LTD

                  •  

                    236,718

                  • +14.60%

                  • 1.74

                  • Verition Fund Managegment, LLC

                  •  

                    110,700

                  • -64.32%

                  • 0.81

                  • Morgan Stanley Smith Barney LLC

                  •  

                    90,125

                  • +360.62%

                  • 0.66

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Biotechnology

                  Type

                  -

                  Style

                  Small Growth

                  Alcobra Ltd is a biopharmaceutical company which engaged in the development and commercialization of its proprietary oral drug candidate, MDX, to treat ADHD and other cognitive dysfunctions including Fragile X Syndrome.

                  Key People

                  Dr. Yaron Daniely, PhD

                  President/CEO/Director

                  Mr. Howard B. Rosen

                  Director/Chairman of the Board

                  Ehud (Udi) Gilboa

                  Co-Founder/Director

                  Dr. Dalia Megiddo, M.D.

                  Co-Founder/Director

                  Dr. Tomer Berkovitz

                  CFO

                  • Alcobra Ltd

                  • Amot Investment Building, 9th Floor

                  • Tel Aviv, 6423902

                  • ISR.Map

                  • Phone: +972 722204661

                  • Fax: -

                  • alcobra-pharma.com

                  Incorporated

                  2008

                  Employees

                  9

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: